Assessment of ethnic differences in sunitinib outcome between Caucasian and Asian patients with metastatic renal cell carcinoma: a meta-analysis.

CONCLUSION: Ethnic differences in adverse events of sunitinib in mRCC patients existed and dose adjustment in Asian patients may be considered.
PMID: 27924664 [PubMed - as supplied by publisher]

Source: Acta Oncologica - December 6, 2016 Category: Cancer & Oncology Authors: Liu X, Fiocco M, Swen JJ, Guchelaar HJ Tags: Acta Oncol Source Type: research